Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ambler

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
Optimisation of the P2 pharmacophore in a series of thrombin inhibitors: ion-dipole interactions with lysine 60GJ Ambler, L Brown, X L Cockcroft, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2000
The design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitorsJ Hayler, P D Kane, D LeGrand, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2000
The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 positionU Baettig, L Brown, D Brundish, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Studies towards the identification of potent, selective and bioavailable thrombin inhibitorsJ Ambler, E Baker, D Bentley, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of thrombin inhibitors: analogues of MD-805 with reduced stereogenicity and improved potencyD Brundish, A Bull, V Donovan, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
Optimisation of the P2 pharmacophore in a series of thrombin inhibitors: ion-dipole interactions with lysine 60GJ Ambler, L Brown, X L Cockcroft, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2000
The design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitorsJ Hayler, P D Kane, D LeGrand, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2000
The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 positionU Baettig, L Brown, D Brundish, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Studies towards the identification of potent, selective and bioavailable thrombin inhibitorsJ Ambler, E Baker, D Bentley, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of thrombin inhibitors: analogues of MD-805 with reduced stereogenicity and improved potencyD Brundish, A Bull, V Donovan, et al.
Pageof 5